COMMUNIQUÉS West-GlobeNewswire

-
WeightWatchers Completes Financial Reorganization, Strengthens Leadership, and Expands Program Innovation to Support Women Through Menopause
08/07/2025 -
Comphya Closes Oversubscribed CHF 7.5 Million Series A Round to Advance U.S. and Australian Clinical Programs Following Strong Pilot Data
08/07/2025 -
Medicines for Poland lance un avertissement : sans usines pharmaceutiques, aucune guerre ne pourra être gagnée en Europe
08/07/2025 -
Les Émirats arabes unis approuvent le complément Longevity+ de BioAro, ouvrant la voie à un fort potentiel sur le marché mondial de la santé préventive
08/07/2025 -
UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
08/07/2025 -
AB Science announces the successful completion of a EUR 1.925 million private placement
08/07/2025 -
AB Science annonce le succès d'un placement privé de 1,925 millions d'euros
08/07/2025 -
Novartis receives approval for first malaria medicine for newborn babies and young infants
08/07/2025 -
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
08/07/2025 -
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
08/07/2025 -
Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon
08/07/2025 -
Aerolib Healthcare Solutions Unveils Aerolib AI: The Ultimate Appeals Machine
08/07/2025 -
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware
07/07/2025 -
FibroBiologics’ to Present at Exclusive Live Investor Webinar and Q&A Session on July 10
07/07/2025 -
SafeSpace Global Corporation welcomes Katie Piperata as its Vice President of Senior Living
07/07/2025 -
NANOBIOTIX Announces Regulatory Harmonization and New Composition of Matter Patent Filed for JNJ-1900 (NBTXR3)
07/07/2025 -
NANOBIOTIX annonce une harmonisation réglementaire et le dépôt d’une demande d’un nouveau brevet de composition de matière pour JNJ-1900 (NBTXR3)
07/07/2025 -
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders
07/07/2025 -
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
07/07/2025
Pages